Evidence Hub

Wearable sweat nicotine biosensor based on a nicotine oxidoreductase and its natural electron acceptor

Zhehao Zhang, Abdurrahman Addokhi, Kristin A. Hughes, Hao Zang, Maria Del Carmen Piqueras, Uroš Kuzmanović, Roger Charles, Leslie Leung et al.

bioRxiv (Cold Spring Harbor Laboratory), 2025

Abstract

Abstract The advent of wearable biosensors is empowering clinical and lifestyle decision making. Nicotine is a drug of significant negative impact on public health given the prevalence of smoking and vaping. Yet noninvasive, continuous monitoring of nicotine is challenging due to lack of specific and sensitive biosensing elements. Here, we report a wearable highly sensitive nicotine biosensor and demonstrate on-body deployment of the sensor in a first-in-human study. The biosensor comprises nicotine oxidoreductase (NicA2) with its natural cytochrome c electron acceptor (CycN) as mediator: both proteins play a key role in the nicotine-degrading bacterium, Pseudomonas putida S16 . The biosensor detects nicotine over four-orders of magnitude (0.1-100 μM) with nanomolar sensitivity (LOD ∼33.6 nM), performs in the physiological pH range (pH 6-9), and is highly selective against common interferants and the major human nicotine metabolite, cotinine. Incorporation of the biosensor in a custom wearable device enables real-time measurement of nicotine from locally induced sweat on volunteer subjects and demonstrates higher analytical accuracy than gold-standard mass spectrometry.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free